Sotac Pharmaceuticals Ltd IPO |
Registered Office:
Plot No PF-21 Nr ACME Pharma,Opp Teva Pharma Sanand GIDC-II
,
Ahmedabad
-
382110
,
Gujarat
, India.
Phone :
91-90819 93300 Fax:
Email : compliance@sotacpharma.com
Website : www.sotacpharma.com
|
| Initial public issue of 3000000 equity shares of face value of (Rs)10/- each of Sotac Pharmaceuticals Limited ("SPL" or the "Company" or the "Issuer") for cash at a price of (Rs)111/- per equity share including a share premium of (Rs)101/- per equity share (the "Issue Price") aggregating to (Rs)33.30 crores ("The Issue"), of which 150000 equity shares of face value of
(Rs)10/- each for cash at a price of (Rs)111/- per equity share including a share premium of (Rs)101/- per equity share aggregating to (Rs)1.67 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 2850000 equity shares of face value of (Rs)10/- each at a price of (Rs)111/- per equity share including a share premium of
(Rs)101/- per equity share aggregating to (Rs)31.63 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 27.15% and 25.79%, respectively, of the post issue paid up equity share capital of the company.
The face value of the equity shares is (Rs)10/- each.
|
| Issue |
Money Payable On |
| Opens On |
Closes On |
Application |
Allotment |
| 29-Mar-23 |
03-Apr-23 |
(Rs)111.00-0.00 |
(Rs)0.00-0.00 |
| Minimum Application for shares in Nos :1200 Further Multiples of :1200 |
| |
(Rs Cr) |
Lead Managers to the Issue |
| Project Cost |
31.10 |
| Beeline Capital Advisors Pvt Ltd |
|
| Project Financed through Current Offer |
33.30 |
|
| Post Issue Equity Share Capital |
11.05 |
|
| Issue Price |
(Rs)111.00 |
|
|